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Introduction 
 A person’s diet is a highly modifiable facet of lifestyle someone can change in order to 
alter their internal bodily processes. One of these processes is inflammation. While inflammation 
is beneficial as part of an acute immune response, it can become detrimental to a person’s health 
if it becomes chronic. There are many dietary factors that can be examined in order to avoid or 
diminish chronic, unwarranted, inflammation. This paper focuses on how people can change 
their dietary patterns to control symptoms of Inflammatory Bowel Disease (IBD), an immune-
mediated inflammatory condition that is heavily influenced by excessive inflammation in the 
digestive tract. Day-to-day dietary changes that can create an anti-inflammatory effect include an 
overall elimination technique through following The Autoimmune Protocol, limiting residue 
within the diet, and meeting adequate requirements of omega-3 polyunsaturated fatty acids (n-3 
PUFAs).  
Inflammation and its Regulation 
 Inflammation is a normal response within the body, as an integral part of the innate 
immune system. The initiation of inflammation aims to eliminate pathogens that may cause 
tissue damage. Inflammation is essential in the immune response as it allows for many types of 
immune cells, such as neutrophils, to migrate to an infected area and recognize a pathogen they 
need to attack. While this beneficial reaction is meant to be acute, some people can experience 
chronic inflammation as well. This chronic inflammation can cause tissue damage and, if left 
untreated, organ damage. This may seem counterintuitive due to the fact that inflammation is a 
mechanism of the immune system, used to protect the body, but a response is not always 
warranted (Bauman, 2017). 
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One common reason for unwanted inflammation in the body, as seen in many chronic 
diseases, is the formation of immune complexes. These immune complexes are constructed when 
multiple antibody-antigen units bind to each other and become a mesh-like network (Bauman, 
2017). If these complexes are large, they can get stuck in blood vessels, and thus activate an 
immune response, inducing inflammation, even though there is no pathogen threatening a 
person’s tissues. Over time, these immune complexes can cause chronic, widespread, 
inflammation (Bauman, 2017). This is only one of the many ways in which there is an abnormal 
T cell immune response stimulated within the body. There are many causes of abnormal T cell 
function, which typically lead to inflammation. When T cells are not regulated correctly, they 
begin to recognize a pathogen, or even non-pathogenic cells, as foreign, and then induce more 
inflammation with a positive feedback loop (Bauman, 2017). These abnormalities cause the type 
of inflammation that worsens chronic diseases. One chronic disease that displays a dysregulation 
of T cells is IBD. In IBD, the microbiome of the gut is thrown off balance and the lack of 
diversity of bacteria in this microbiome can lead to the misregulation of T cells (Kostic et al., 
2014). 
 The microbiome is the collection of microorganisms such as bacteria, fungi, genetic 
material, or even viruses that live in and on your body (Bauman, 2017). Each individual has a 
unique microbiome within their gastrointestinal (GI) tract, or their gut. This microbiome can help 
synthesize vitamins, absorb vitamins and minerals, digest food, enhance nutrition, inhibit the 
growth of pathogens, prevent infection, and even keep your immune system healthy. 
Fermentation is carried out by the bacterial colonies that are part of this microbiome. 
Fermentation is the process by which microorganism such as bacteria in the gut break down 
foods such as carbohydrate or fiber into usable acids such as short-chain fatty acids. The 
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byproducts of fermentation by the gut microbiota are helpful in providing energy for epithelial 
cells lining the GI tract and can aid in enhancing the integrity of the epithelial barrier of the gut 
(Bauman, 2017). This epithelial integrity is important because it prevents any leakage of contents 
from the gut inside the body, which may cause an immune response led by T cells. Gut dysbiosis 
occurs when this microbial community is altered in a way that decreases the number and 
diversity of bacteria. Gut dysbiosis is associated with many chronic health conditions, one of 
which is IBD (Bauman, 2017). 
IBD 
 IBD is a group of disorders that lead to the chronic inflammation of the GI tract. Two 
types of IBD include Chron’s Disease and Ulcerative Colitis. Chron’s Disease mainly affects the 
final portion of the small intestine but can ultimately affect any part of the GI tract. Ulcerative 
Colitis is defined by the long-term inflammation and formation of ulcers in the lining of the large 
intestine and rectum (Kostic et al., 2014). A major factor in the possible development of IBD is 
the microbial community of the gut. It is suggested that IBD can be due to the dysregulation of 
the mucosal immune system as a result of specific changes in the microbiome (Knox et al., 
2019).This then causes dysbiosis in the intestinal lining, which leads to chronic 
inflammation.  Dysbiosis in the lining of the intestines begins with a genetic abnormality that 
makes the host more susceptible and is followed by the ways in which the microbiome of the gut 
responds to its environment (Knox et al., 2019).  
  Until recently, IBD was thought of as an autoimmune disease because it was originally 
assumed that the chronic inflammation seen with this condition was due to the immune system 
attacking itself, but this is not actually the case (Kostic et. al., 2014). Instead, the microbiome of 
the gut is attacking “harmless” viruses, bacteria, or food products that pass through the GI tract, 
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which is causing the chronic swelling and damage to the intestines that characterize IBD. Experts 
now believe that IBD results from altered interactions between intestinal microbes and the 
mucosal immune system (Kostic et. al., 2014). Because of these factors, IBD is no longer 
classified as an autoimmune disease. Instead, it is considered an immune-mediated inflammatory 
disease (Knox et al., 2019).  
 Immune-mediated inflammatory diseases lack any definitive etiology. They are identified 
by common inflammatory pathways leading to inflammation, which is triggered by a 
dysregulation of the normal immune response. In the case of IBD, this dysregulation is cause by 
dysbiosis within the gut. These diseases have been seen to occur in people who have specific 
genetic mutations which make them more susceptible when they have an overactive 
immunological response which is initiated and then later reactivated by exposure to 
environmental stimuli. The presence of overactive immunological responses makes these 
diseases similar to autoimmune diseases because the host has an overactive immune response, 
but they are different because the response is not to a stimulus that originates within the body, 
but one that comes from the environment (Knox et al., 2019).  
Dietary Intake and IBD 
Recent studies have shown that the rates of patients with IBD is increasing greatly over 
the years, suggesting that genetics and a person’s immune response are not the only major factors 
that determine whether or not a person develops this disease (Kostic et al., 2014). Instead, 
environment is playing a large role in this determination, and diet is one way in which a person 
can change the environment and the microbiome which resides in their digestive system. Long-
term dietary decisions impact the types of microorganisms that grow and flourish in a person’s 
gut, whether they be healthy or not (Kostic et al., 2014). Because of the large environmental 
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impact on IBD, a person’s dietary patterns can very easily influence inflammation and have a 
negative impact on their symptoms and reoccurrence of IBD. Luckily, a healthier and more 
structured diet can be a possible solution to help decrease systemic inflammation and manage, or 
even decrease, symptoms of IBD (Richards et al., 2016). The focus of dietary patterns used to 
decrease gut inflammation should be on anti-inflammatory foods. This includes, but is not 
limited to, foods allowed through an elimination-based diet, a focus on nutrient-dense foods, 
lowering the amount of residue in the diet and meeting adequate requirements of n-3 PUFAs. 
Nutrient dense foods contain high amounts of nutrients, such as essential vitamins and minerals, 
and have relatively low calories compared to other foods in the same proportions.  
A major contributing factor of dietary patterns which increase systemic inflammation has 
to do with a person’s gut microbiome. Although humans are born with very unique microbiomes, 
these microbiomes constantly adapt over time, and diet can play a central role in the alterations 
within the microbiome (Richards et al., 2016). A person’s digestive tract is one of many large 
mucosal surface areas within the body, which means it is also home to many T cells and other 
immunoregulatory cells. It has been recognized that what a person puts into their body can affect 
the microbiome of their gut by changing the types of bacteria that may be growing there 
(Richards et al., 2016). The specific bacteria that grow in a person’s gut can then affect the health 
of these mucosal layers, which can help maintain healthy function of T cells and other 
immunoregulatory cells.  
Autoimmune Protocol Diet 
The Autoimmune Protocol Diet (AIP) is a dietary protocol meant to mimic ideas behind 
following the “Paleolithic Diet”, to eliminate any foods that do not seem to be tolerated well by 
the bacteria in many people’s gut microbiome and may cause it to be compromised. The main 
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goal of the AIP is to eliminate any factors of the Western diet that cause inflammation or other 
immune responses and to replace them with more nutrient-dense foods that have healthier effects 
on our gut microbiome and body in general. While IBD is not an autoimmune disease, it is 
triggered by a dysregulation of the body’s normal immune response and acts like an autoimmune 
disease of the gut.  
The first part of this protocol is considered an elimination phase, in which a person cuts 
out many foods within their diet that may be harming their microbiome (Konijeti et al., 2017). 
The food groups that are eliminated during this initial phase include grains, legumes, eggs, dairy, 
nuts and seeds, coffee, alcohol, refined/processed sugars, nightshades, industrial seed oils, as 
well as food additives and nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin or 
ibuprofen. Nightshades are foods that may appear healthy at first but are not tolerated well by all 
individuals, such as tomatoes, eggplant, peppers, and more. During the elimination phase, it is 
essential for participants to also focus on eating nutrient-dense foods and probiotics, and to pay 
attention to how their foods are prepared to avoid losing nutrients. Some of the foods that are still 
options for people to eat once they are going through this elimination phase would be lean meats 
and fish, vegetables (excluding nightshades), fruits, plant-based milks such as coconut milk, 
fermented foods, and other foods which do not fall into the categories listed above. The second 
phase of this diet is a maintenance phase, when a person should continue with this new diet from 
the initial phase until their symptoms improve. At this point, a person moves into the 
reintroduction phase by slowly reinstating specific foods in stages to determine which foods or 
food groups are symptomatic triggers (Konijeti et al., 2017). 
 A study done by Konijeti et al. (2017) investigated how the AIP  specifically affects IBD. 
Although this study only followed participants during the elimination phase (6 weeks) and the 
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maintenance phase, not the reintroduction phase, the results were still very informative. By the 
end of the 6-week elimination phase, 11 out of 15 (73%) of the participants were in remission 
from IBD altogether. This is a significant discovery, especially considering that the most 
effective IBD drug treatments only have an average of a 50% remission rate (Konijeti et al., 
2017). Along with these results, there was also a reduction in fecal calprotectin (FC) and 
refinement in mucosal inflammation as viewed through endoscopy in patients after following this 
diet. FC is used as a measure to determine the number of neutrophils that travel to the intestinal 
mucosa, which is caused by inflammation (Konijeti et al., 2017).  So, this means that, 
implementing this dietary change can help people with IBD alleviate some of their symptoms, 
and possibly even move into remission.  
 In 2019, a follow-up study was performed by Chandrasekaran et al. This was a 
randomized control trial which was performed on 9 participants with Crohn’s disease , and 6 
who had Ulcerative Colitis  that was focused on examining the quality of life changes between 
participants. Like the previous study, this new trial examined participants through the 6-week 
elimination phase of the AIP, in which certain foods were eliminated in a staged fashion over 
time. It also followed participants for a 5-week maintenance phase after the eliminations, in order 
to assess the outcomes of the eliminations. Participants filled out the Short Inflammatory Bowel 
Disease Questionnaire (SIBDQ) at baseline and weeks 3, 5, 9, and 11 to assess how the dietary 
changes may have improved their quality of life. The results of this study showed that in both 
Chron’s disease and ulcerative Colitis patients, while the questionnaire scores were different 
between these two subgroups, the scores for each subgroup significantly improved by week 11 of 
the trial. Results of the improved quality of life were significant as early as week 3 of the dietary 
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intervention, showing how diet can not only help alleviate symptoms of such an uncomfortable 
disease, but also improve a patient’s quality of life (Chandrasekaran et al., 2019).  
The AIP diet can be followed in contrast to diets like the Western diet which include 
excess of certain food groups, and are specifically high in saturated fats, which have been 
commonly linked to increased systemic inflammation. A high-fat Western diet leads to extra fat 
stores and adipose tissue within the body which chronically manipulate regulatory T cells of the 
immune system. As explained previously, the dysregulation of these regulatory T cells can create 
an unwanted inflammatory response, and in this case, it creates a low-grade response. This 
would not typically be a problem, except in the case of diet. Consuming a Western diet is a 
chronic pattern that makes this inflammatory response chronic as well (Manzel et al., 2014). 
Without changes in dietary habits, there is no change within the body to help with this 
chronically increasing inflammation. Even if a person decides to change their eating habits for a 
week or two, this will not be enough. The inflammation stimulated by an excessively high-fat 
diet stems mainly from the adipose tissue cells that form within the person’s body (Manzel et al., 
2014). To decrease these inflammatory responses, a person needs to change their dietary habits 
for an extended period of time in order to give their bodily systems time to adjust. 
Low Residue Diets 
One food component that has been shown to have a great effect on the microbiome and 
the mucosal layers of the gut is fiber. Although the body cannot digest fiber, the gut bacteria can 
ferment some forms of fiber, creating helpful metabolites such as short-chain fatty acids 
(SCFAs) (Richards et al., 2016). SCFA have anti-inflammatory effects by controlling the number 
of regulatory T cells and their functioning abilities within the colon. Along with direct gut health, 
the article written by Richards et al. (2016), explains how SCFAs can help increase the 
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generation of T regulatory cells via epigenetic effects. This allows immune cells to work 
throughout the whole body in order to have more power over autoreactive lymphocytes, which 
can help prevent the development of or decrease the symptoms of immune-mediated 
inflammatory diseases (Richards et al., 2016). 
SCFAs can help keep the mucosal layer of the gut healthy. Without an adequate 
production of SCFA, the function of the intestinal mucosal barrier will begin to break down, 
making it “leaky” (Richards et al., 2016). When there is a leakage in this barrier, an immune 
response will be created by T cells and immunoglobulin-A (IgA) antibodies. This immune 
response will also create an increase in inflammation. Along with this immediate immune 
response, there is a greater likelihood that pathogenic bacteria will attach to the gut mucosal 
surface when it is not protected as well. This will also cause an inflammatory immune response 
(Dolan & Chang, 2017). While there is currently much controversial evidence as to whether or 
not leaky gut syndrome is a real diagnosis, there is evidence that shows that permeability of the 
intestinal lining does still occur and lead to inflammation (Fasano, 2012). 
There are many different types of fiber, and it is very important for people with IBD to 
know which types of fiber they are eating in order to gain the desired effects. A study by Kuo 
(2013), compared previous clinical trials in which fermentable fibers were incorporated into the 
diet and inflammatory markers within the body were measured. Kuo’s review explained the 
previous discrepancies as to why certain studies were not showing significant results and 
ultimately suggested that an introduction of adequate amounts of fermentable fiber into a 
person’s diet decreases the number of inflammatory markers present (2013). Fermentable fibers 
can be found mainly in beans and legumes. The current adequate intake recommendation of fiber 
is between 25-38 grams per day of total fiber (Institute of Medicine, 2005). Along with 
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fermentable fiber, soluble fiber has also been seen to decrease inflammation. A study done by 
Morrison et al. in 2019, demonstrated how diets without adequate soluble fiber were shown to 
increase systemic inflammation and to promote a poor nutritional environment of the gut in 
mice. This study was performed because previous research overlooked the role of soluble fiber 
on different diseases. In this study, mice were transferred from a chow diet to a low-soluble fiber 
diet. This shift was seen to increase the systemic inflammation of the rodents, and they lost 
specific taxa of bacteria in the gut microbiome which were important to the environmental health 
of the gut (Morrison et al., 2019).  
The low-residue diet focuses on digestibility of food intake and emphasizes consumption 
of different types of fiber. In the case of a low-residue diet, residue is an umbrella term for any 
type of food that is poorly digested (Hwang et al., 2014). While people automatically assume that 
this means fiber as a whole and attempt to cut fiber out of their diet completely, it specifically 
refers to insoluble fibers. Soluble and fermentable fibers are still beneficial to digestion and are 
recommended within a person’s diet. While this is the case, many foods that have one type of 
fiber also have others, this is why a person following a low-residue diet should limit their 
insoluble fiber intake and they should try to focus on what kind of fiber is in the foods they are 
preparing. Studies on this diet suggest that a lower recommendation of fiber, specifically 10-15 
grams per day, is more beneficial in order to avoid taking in too much insoluble fiber which can 
be found in foods that also contain soluble and fermentable fiber types. Beneficial soluble fibers 
can be found in food such as oatmeal, peeled fruits, nuts, seeds, and more (Hwang et al., 2014). 
Below is a chart that shows how many of the foods that are high in soluble fiber, have a large 
amount of insoluble fiber as well. 
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Table 1: Shows the amount of soluble and insoluble fiber in high fiber foods (adapted from 
Jackson GI Medical, 2020)  
Food Serving Size Total Fiber 
(Grams) 
Soluble Fiber  
(Grams) 
Insoluble fiber 
(Grams) 
Apple (Peeled) 1 Apple 2.40 0.70 1.70 
Black Beans 1 Cup 5.30 1.40 3.90 
Broccoli (Fresh 
Cooked) 
1 Cup 4.60 2.30 2.30 
Brussel Sprouts 
(Cooked) 
1 Cup 6.40 3.90 2.50 
Carrots (Raw) 1 Cup 3.30 1.60 1.70 
Green Peas 
(Cooked) 
1 Cup 8.80 2.60 6.20 
Lentils 1 Cup 7.30 1.10 6.40 
Lima Beans 
(Cooked)  
1 Cup 13.20 7.00 6.20 
Oatmeal 1 Cup 4.00 1.90 2.10 
Soybeans 
(Roasted) 
1 Cup 30.40 13.70 16.70 
Sunflower 
Seeds 
1 Cup 13.40 2.70 10.70 
Whole Wheat 1 Slice of Bread 0.20 0.10 0.10 
 
Omega-3 Enriched Diets 
Another main element of the typical Western diet that leads to systemic inflammation is 
the overconsumption of saturated fatty acids (SFA). These types of fatty acids can typically be 
found in animal foods such as different types of meat or high-fat dairy products. As mentioned 
before, dietary habits have a direct effect on the microbiome within a person’s gut. High-fat 
foods, specifically foods high in saturated fat, increases the release of lipopolysaccharides (LPS) 
from the gut bacteria into the bloodstream and can lead to metabolic endotoxemia. This then 
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causes the activation of toll-like receptor-4 (TLR4) complexes and their subsequent 
inflammatory pathways. This can lead to a more chronic form of inflammation, which is the type 
of inflammatory reaction that is seen in IBD and other chronic inflammatory diseases (Rocha et 
al., 2016). 
One way to reduce systemic inflammation is to lower consumption of SFAs. While this 
can help with the problem of systemic inflammation, many people replace these fats with 
unhealthy, high glycemic index carbohydrates. A healthier, and even anti-inflammatory, 
alternative to this approach is to replace SFAs with unsaturated fatty acids. More specifically, a 
person should replace SFAs with n-3 PUFAs which have a very positive effect of antagonizing 
unnecessary systemic inflammation (Calder & Grimble, 2002). 
While it is important to consume both n-6 and n-3 PUFAs, many people do not consume 
these products in correct proportions (Simopoulos, 2008). Most people eat many more n-6s which 
is most likely due to their abundance in commonly consumed foods such as nuts, seeds, and oils 
(Mayo Clinic, 2019). Fish and fish oils are the main sources of n-3s, which many people do not 
incorporate into their diets enough. In order to eat the correct proportions of n-3s to n-6s, the 
World Health Organization recommends that people incorporate two servings of fish into their 
diet each week as an adequate source of n-3s (Kris-Etherton et al., 2009). It has also been 
determined that n-6s compared to n-3s  should be consumed in a ratio of 4:1, so the 
recommended amount of n-6s that a person should eat will depend on their n-3 intake 
(Simopoulos, 2008). 
The common discrepancy between how much of each nutrient is eaten is important 
because n-6s increase the amount of arachidonic acid in the body, and n-3s increase 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Arachidonic acid increases a 
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person’s eicosanoids which can help regulate the intensity and duration of inflammation during 
an immune response (Calder & Grimble, 2002). These eicosanoids can have many different 
effects, some of which can be pro-inflammatory, and others which can be immunosuppressive. In 
contrast to this, EPA from fish oils has been seen to competitively inhibit the oxygenation of 
arachidonic acid. After the inhibition, EPA-derived eicosanoids are produced instead of the 
eicosanoids produced by arachidonic acid. These EPA eicosanoids have anti-inflammatory 
effects and they can enhance immune function (Calder & Grimble, 2002). 
There are two separate ways in which n-3 and n-6 PUFAs battle over whether or not an 
inflammatory response will be induced. These two methods are through the activation of TLRs 
and the formation of different types of eicosanoids. A study done by Weatherill et al. in 2005 
was aimed at determining whether or not either saturated or unsaturated fatty acids alter immune 
responses as a result of the regulation of TLR signaling pathways and the genes they helped 
express within dendritic cells. Although the main aim of this study was not focused on the 
inflammatory effects of these fatty acids, these responses were discussed in the results. This 
study compares the SFA lauric acid, and the n-3 PUFA, DHA. Within this study, it was 
determined that lauric acid activates TLR4 and DHA was an antagonist to this activation. The 
activation of these TRL4s is the main mechanism of initiating an immune response within the 
body, and the main component of this immediate immune response is inflammation. This is why 
it is important to recognize that DHA fails to stimulate unhealthy receptors, but it also 
antagonizes their activation. By incorporating more n-3 PUFAs into the diet, a person can reduce 
any systemic inflammation which may be causing them harm. (Weatherill et al., 2005) 
Like the study explained above, Calder and Grimble (2002) directly examined the effects 
of n-3 PUFA supplementation and its effects on diseases that may owe their pathogenesis to 
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chronic inflammation. This study focused more on the types of eicosanoids that are produced by 
each type of fatty acid, and how they lead to, or inhibit, inflammation. As explained in the 
previous section of this paper, the n-6 PUFA, arachidonic acid, is what stimulates the growth of 
inflammatory eicosanoids, and the n-3 PUFAs, DHA and EPA, are arachidonic acid antagonists 
(Calder & Grimble, 2002). A person can use this information to recognize that it is necessary to 
meet the recommended amount of n-3 PUFAs each week to counteract the inflammatory effects 
of arachidonic acid.  
 While dietary n-3s are mainly found in seafood, there are many people that do not 
incorporate any seafood into their diet. Because of this, many people have studied the effects of 
n-3 supplementation in order to create the correct balance of n-3s and n-6s that they are 
consuming. A study done by Costenbader et al. in 2019 performed a  randomized clinical trial to 
study the effects of marine n-3 and vitamin D supplements. These trials were not able to find any 
definitive positive effects of either supplement on biomarkers of systemic inflammation 
(Costenbader et al., 2019). While this is the case, there were many flaws within this study that 
were recognized, and which should be reviewed.  
Despite the lack of findings, it is still a high possibility that n-3 supplements can be 
beneficial for those who do not already include fish within their diet, and more randomized 
control studies must be done to determine whether or not this is the case (McKinley, 2019). 
There are also no known adverse health effects of these supplements which is why they are better 
than no source of n-3s at all (McKinley, 2019). 
Conclusion: 
As described above, changing a person’s diet can ultimately change the way in which 
their immunoregulatory cells function. While decreasing inflammation in the gut is not a cure for 
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immune-mediated inflammatory diseases like IBD, it can greatly improve symptoms for people 
diagnosed with this disease. The best way to use diet as a regulatory tool is to follow the AIP, 
limit the consumption of poorly digested foods, and incorporate adequate n-3 PUFAS, while 
limiting SFAs, in their daily meals. People who change their dietary patterns in this way are able 
to incorporate more nutrient-dense foods and avoid foods that their body cannot tolerate. Each of 
these changes has its own anti-inflammatory effect, and all together these changes create a 
significant decrease in systemic inflammation. This can greatly improve chronic inflammation 
and symptoms of IBD.  
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